In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Vulnerable Plaque: Medical Device's New Biological Frontier

Executive Summary

As interest in vulnerable plaque heats up, medical device companies hope to capitalize on their earl y lead. But as vulnerable plaque shifts therapies from structural to biological, that lead many not last long. The second of a two-part series.

Related Content

On The Hunt For Vulnerable Plaque InfraReDx Improves Stenting Safety
Prescient Medical's Dual Approach to Vulnerable Plaque
World Congress of Cardiology: DES Safety Dominates Discussions
InfraReDx: Saved by Angels (and a VC)
Volcano's Second Act
Magnetic Moment
Guidant Shines Light on Vulnerable Plaque with Miravant Deal
Our Top Ten Items from a Year Most Want to Forget
Vulnerable Plaque Heats Up
Vulnerable Plaque Heats Up


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts